Use of the Rapid Antigenic Test to Determine the Duration of Isolation in Infants Hospitalized for Respiratory Syncytial Virus Infections

Abstract

Infants hospitalized for bronchiolitis associated with respiratory syncytial virus are isolated for the duration of their hospitalization. This article reviews whether a negative rapid antigenic test could be used to shorten the duration of isolation measures. Rapid respiratory syncytial virus tests were performed from day 3 on alternate days in all patients hospitalized for bronchiolitis. Isolation measures were removed when the test result was negative. The result of the antigenic test was confirmed by viral culture and polymerase chain reaction. Surveillance of nosocomial cases was performed daily. Forty-one patients were analyzed. On day 3, 51.2% of patients were negative by viral culture and 56.1% were negative by rapid testing. On day 5, a further 26.8% were negative by viral culture and 31.7% by rapid testing. The rapid antigen test had a low sensitivity at 60% and a specificity of 76% compared with viral cultures; therefore this test alone cannot be used to lift isolation measures.

Keywords

respiratory syncytial virus contagiousness antigenic testing.

Get full access to this article

View all access options for this article.

References

Abels S. , Nadal D. , Stroehle A. , Bossart W. Reliable detection of respiratory syncytial virus infection in children for adequate hospital infection control management. J Clin Microbiol . 2001;39:3135-3139.

Boyce TG , Mellen BG , Mitchel EF, Jr. , Wright PF , Griffin MR Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137:865-870.

Shay DK , Holman RC , Newman RD , Liu LL , Stout JW , Anderson LJ Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282: 1440-1446.

Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report. Guidelines for Preventing Health-Care-Associated Pneumonia, 2003. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm. Accessed October 24, 2007.

Centers for Disease Control and Prevention. Guidelines for Environmental Infection Control in Health-Care Facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HIC-PAC) Atlanta, GA: CDC; 2003.

Hall CB The shedding and spreading of respiratory syncytial virus. Pediatr Res. 1977;11:236-239.

Ohm-Smith MJ , Nassos PS , Haller BL Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus. J Clin Microbiol. 2004;42:2996-2999.

Waner JL , Whitehurst NJ , Todd SJ , Shalaby H. , Wall LV Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. J Clin Microbiol. 1990;28:480-483.

Garbino J. , Gerbase MW , Wunderli W. , et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med. 2004;170:1197-1203.

10.

Dewhurst-Maridor G. , Simonet V. , Bornand JE , Nicod LP , Pache JC Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus. J Virol Methods. 2004;120:41-49.

11.

Bordley WC , Viswanathan M. , King VJ , et al. Diagnosis and testing in bronchiolitis: a systematic review . Arch Pediatr Adolesc Med. 2004;158:119-126.

12.

Casiano-Colon AE , Hulbert BB , Mayer TK , Walsh EE , Falsey AR Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol. 2003;28:169-174.